Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topotecan plus Carboplatin in recurrent ovarian cancer
NCT00437307Phase 3Completed
- Sponsor
- NOGGO
- Start
- Mar 2007
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of topotecan in ovarian cancer, primary peritoneal cancer (PPC), fallopian tube cancer (PFTC), sponsored by NOGGO. Started Mar 2007; status: completed.
02
Drugs
topotecan
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)fallopian tube cancer (PFTC)
Beyond the preview
Go deeper on NCT00437307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00437307.